Literature DB >> 20727473

Trichomonas vaginalis transcription-mediated amplification-based analyte-specific reagent and alternative target testing of primary clinical vaginal saline suspensions.

Erik Munson1, Maureen Napierala, Janice Basile, Cheryl Miller, Jason Burtch, Jeanne E Hryciuk, Ronald F Schell.   

Abstract

Following wet mount analysis, 255 vaginal saline suspensions were aliquoted to lysis medium for transcription-mediated amplification (TMA)-based Trichomonas vaginalis analyte-specific reagent testing (ASR) (Gen-Probe, San Diego, CA). Specimens with visible T. vaginalis were then refrigerated, with additional aliquoting at later intervals. Twenty-four wet mount-positive specimens (9.4%) yielded a median luminescent value (x1000, relative light unit [RLU]) of 4736. In contrast, RLU ranged from 1 to 21 following ASR of 204 wet mount-negative specimens. Twenty-seven wet mount-negative specimens (10.5%) were positive by ASR and subsequently positive via T. vaginalis alternative target TMA (Gen-Probe). Discrepancies were additionally resolved by demonstration of T. vaginalis nucleic acid from a separate endocervical collection. T. vaginalis nucleic acid was detectable following prolonged storage, following minimal incubation in lysis medium, and from low-volume aliquots of sparsely populated specimens. T. vaginalis ASR adequately detects T. vaginalis from vaginal saline suspension aliquots, providing a simple specimen alternative for a highly sensitive laboratory diagnosis of trichomoniasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727473     DOI: 10.1016/j.diagmicrobio.2010.05.002

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  11 in total

1.  Suboptimal Trichomonas vaginalis Antigen Test Performance in a Low-Prevalence Sexually Transmitted Infection Community.

Authors:  Kimber L Munson; Maureen Napierala; Erik Munson
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

2.  Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial.

Authors:  Jane R Schwebke; Marcia M Hobbs; Stephanie N Taylor; Arlene C Sena; Michael G Catania; Barbara S Weinbaum; Ann D Johnson; Damon K Getman; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

3.  Female epidemiology of transcription-mediated amplification-based Trichomonas vaginalis detection in a metropolitan setting with a high prevalence of sexually transmitted infection.

Authors:  Erik Munson; Timothy Kramme; Maureen Napierala; Kimber L Munson; Cheryl Miller; Jeanne E Hryciuk
Journal:  J Clin Microbiol       Date:  2012-09-26       Impact factor: 5.948

4.  Three-year history of transcription-mediated amplification-based Trichomonas vaginalis analyte-specific reagent testing in a subacute care patient population.

Authors:  Maureen Napierala; Erik Munson; Kimber L Munson; Timothy Kramme; Cheryl Miller; Jason Burtch; Robin Olson; Jeanne E Hryciuk
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

5.  Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications.

Authors:  Sarah B Andrea; Kimberle C Chapin
Journal:  J Clin Microbiol       Date:  2011-01-19       Impact factor: 5.948

6.  Clinical Laboratory Assessment of Mycoplasma genitalium Transcription-Mediated Amplification Using Primary Female Urogenital Specimens.

Authors:  Erik Munson; Holly Bykowski; Kimber L Munson; Maureen Napierala; Pamela J Reiss; Ronald F Schell; Jeanne E Hryciuk
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

7.  Screening of male patients for Trichomonas vaginalis with transcription-mediated amplification in a community with a high prevalence of sexually transmitted infection.

Authors:  Kimber L Munson; Maureen Napierala; Erik Munson; Ronald F Schell; Timothy Kramme; Cheryl Miller; Jeanne E Hryciuk
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

8.  Retrospective assessment of transcription-mediated amplification-based screening for Trichomonas vaginalis in male sexually transmitted infection clinic patients.

Authors:  Erik Munson; David Wenten; Paula Phipps; Roger Gremminger; Mary Kay Schuknecht; Maureen Napierala; Deb Hamer; Robin Olson; Ronald F Schell; Jeanne E Hryciuk
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

9.  Prevalence and predictors of trichomonas infection in newly incarcerated women.

Authors:  Ank E Nijhawan; Kimberle C Chapin; Rachel Salloway; Sarah Andrea; Jessi Champion; Mary Roberts; Jennifer G Clarke
Journal:  Sex Transm Dis       Date:  2012-12       Impact factor: 2.830

10.  PCR for diagnosis of male Trichomonas vaginalis infection with chronic prostatitis and urethritis.

Authors:  Jong Jin Lee; Hong Sang Moon; Tchun Yong Lee; Hwan Sik Hwang; Myoung-Hee Ahn; Jae-Sook Ryu
Journal:  Korean J Parasitol       Date:  2012-05-24       Impact factor: 1.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.